Skip to main content
Ipsen logo

Ipsen — Investor Relations & Filings

Ticker · IPN ISIN · FR0010259150 LEI · 549300M6SGDPB4Z94P11 PA Manufacturing
Open in API
Filings indexed 1,378 across all filing types
Latest filing 2025-04-04 Declaration of Voting R…
Country FR France
Listing PA IPN

About Ipsen

https://www.ipsen.com/

Ipsen is a global biopharmaceutical company focused on innovation and specialty care. The company develops and commercializes transformative medicines to address high unmet medical needs in three key therapeutic areas: oncology, rare diseases, and neuroscience. By leveraging its specialized expertise and strategic partnerships, Ipsen aims to accelerate the development of new therapies and improve health outcomes for patients worldwide. Its strategy is centered on advancing science with purpose to bring innovative treatments from research and development to the market.

Recent filings

Filing Released Lang Actions
Franchissements de seuils
Declaration of Voting Results & Voting Rights Announcements Classification · 1% confidence The document is a formal declaration in French, titled "Déclarations de franchissements de seuils (article L. 233-7 du code de commerce)". This explicitly refers to regulatory filings concerning changes in significant share ownership thresholds, as mandated by French commercial law (Code de commerce). The content details two related entities (Parvus Asset Management Europe Limited and Parvus Asset Management Jersey Limited) crossing the 5% ownership threshold in IPSEN SA on March 31, 2025. This perfectly matches the definition of a Major Shareholding Notification (MRQ), which covers notifications of changes in significant share ownership levels crossing thresholds.
2025-04-04 French
franchissement de seuil
Major Shareholding Notification Classification · 1% confidence The document is titled "Déclaration de franchissement de seuil (article L. 233-7 du code de commerce)" which translates to 'Declaration of crossing a threshold (Article L. 233-7 of the Commercial Code)'. This type of filing in France (AMF regulated) specifically reports when an investor's stake crosses a major ownership threshold (like 5%, 10%, etc.). This directly corresponds to the definition of Major Shareholding Notification (MRQ), which covers 'Notification of changes in significant share ownership levels (crossing thresholds)'. The document details the new holding percentage (4.91% of voting rights) after a decrease.
2025-03-20 French
Ipsen annonce le succès de son émission obligataire inaugurale notée d'un montant de 500 millions d'euros
Capital/Financing Update Classification · 1% confidence The document is an announcement titled "Ipsen annonce le succès de son émission obligataire inaugurale notée d'un montant de 500 millions d'euros" (Ipsen announces the success of its inaugural rated bond issuance of 500 million euros). The text details the successful completion of a financing transaction (issuing bonds), including the amount, coupon, maturity date, and market reception. This content directly relates to fundraising, financing activities, and capital structure changes. This aligns perfectly with the definition for Capital/Financing Update (Code: CAP). It is not an Annual Report (10-K), an Earnings Release (ER), or a general Regulatory Filing (RNS), as it describes a specific corporate finance event.
2025-03-19 French
Ipsen announces issuance of €500 million inaugural Rated Public Bond
Capital/Financing Update Classification · 1% confidence The document is an announcement titled "Ipsen announces issuance of €500 million inaugural Rated Public Bond." It details the successful completion of a bond issuance, coupon rate, maturity date, and the context of refinancing plans. This activity directly relates to the company raising capital or changing its financing structure. This aligns perfectly with the definition for Capital/Financing Update (CAP). It is not an Annual Report (10-K), an Earnings Release (ER), or a general Regulatory Filing (RNS), as it describes a specific financing event.
2025-03-19 English
Ipsen appoints Olivia Brown as Executive Vice-President, Global Head of Neurotoxins
Board/Management Information Classification · 1% confidence The document is explicitly titled "Press release" and announces a significant personnel change: the appointment of Olivia Brown as Executive Vice-President, Global Head of Neurotoxins. This type of announcement, detailing changes in senior management or the board of directors, directly corresponds to the definition of Board/Management Information (MANG). It is not an earnings release (ER), a full annual report (10-K), or a report publication announcement (RPA), as it is the primary content itself, not an announcement about attaching another document. The content focuses entirely on executive leadership changes.
2025-03-12 English
Ipsen nomme Olivia Brown au poste de Vice-Présidente Exécutive, Directrice Mondiale des Neurotoxines
Board/Management Information Classification · 1% confidence The document is a press release dated March 12, 2025, announcing the appointment of Olivia Brown to a new Executive Vice President role (EVP, Global Head of Neurotoxins). This type of announcement, detailing changes in senior management or the board of directors, directly corresponds to the definition of 'Board/Management Information'. The document is not a full financial report (10-K or IR), an earnings release (ER), or a proxy statement (DEF 14A/PSI). Therefore, the appropriate classification is MANG.
2025-03-12 French

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.